Z-2976-2020 Class III Terminated

Recalled by Oxford Immunotec — Abingdon, N/A

FDA device recall Z-2976-2020 was initiated by Oxford Immunotec on Jul 16, 2020 and is designated Class III. Reason for recall: Incorrect expiration date included in test kit labeling and/or in Substrate component label. The recall status is terminated (terminated Sep 13, 2021). Affected quantity: 583 units.

Recall details

Product Type
Devices
Report Date
Sep 23, 2020
Initiation Date
Jul 16, 2020
Termination Date
Sep 13, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
583 units

Product description

Model No:T-SPOT.TB8, Catalogue No.: TB.300; UDI: 1505171600030 - Product Usage: intended for use as an aid in the diagnosis of Mycobacterium tuberculosis infection by detecting effector T cells that respond to stimulation by M. tuberculosis antigens ESAT-6 and CFP10, and capturing interferon-gamma in the vicinity of these cells.

Reason for recall

Incorrect expiration date included in test kit labeling and/or in Substrate component label.

Distribution pattern

Worldwide distribution - U.S. Nationwide distribution including in the states of AL, CO, D.C., GA, ID, IN, MD, OH, PA, TN, TX, and VA. The countries of Austria, Belgium, Czech Republic, France, Germany, Italy, Kuwait, Latvia, Netherlands, Philippines, Saudi Arabia, Singapore, South Korea, Spain, Sweden, Switzerland, Turkey, United Kingdom.

Code information

Manufacturing Kit Lot Numbers: TEC3321847, TEC3041811.

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2976-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2976-2020. Report a data issue: hello@regdatalab.com.